Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Caveat to Using Wearable Sensor Data for COVID-19 Detection: The Role of Behavioral Change after Receipt of Test Results

Jennifer L. Cleary, Yu Fang, View ORCID ProfileSrijan Sen, View ORCID ProfileZhenke Wu
doi: https://doi.org/10.1101/2021.04.17.21255513
Jennifer L. Cleary
1Michigan Neuroscience Institute, University of Michigan, Ann Arbor, MI
2Department of Psychology, University of Michigan, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yu Fang
1Michigan Neuroscience Institute, University of Michigan, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Srijan Sen
1Michigan Neuroscience Institute, University of Michigan, Ann Arbor, MI
3Department of Psychiatry, University of Michigan Medical School
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Srijan Sen
Zhenke Wu
4Department of Biostatistics, University of Michigan, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zhenke Wu
  • For correspondence: zhenkewu{at}umich.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Recent studies indicate that wearable sensors have the potential to capture subtle within-person changes that signal SARS-CoV-2 infection. However, it remains unclear the extent to which observed discriminative performance is attributable to behavioral change after receiving test results. We conducted a retrospective study in a sample of medical interns who received COVID-19 test results from March to December 2020. Our data confirmed that sensor data were able to differentiate between symptomatic COVID-19 positive and negative individuals with good accuracy (area under the curve (AUC) = 0.75). However, removing post-result data substantially reduced discriminative capacity (0.75 to 0.63; delta= −0.12, p=0.013). Removing data in the symptomatic period prior to receipt of test results did not produce similar reductions in discriminative capacity. These findings suggest a meaningful proportion of the discriminative capacity of wearable sensor data for SARS-CoV-2 infection may be due to behavior change after receiving test results.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by grants from the National Institute of Mental Health (R01 MH101459) to S.S. and Z.W. and an investigator grant from Precision Health Initiative at University of Michigan, Ann Arbor to Z.W. and S.S.. J.C. was supported by T32HD007109.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB, University of Michigan, Ann Arbor

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data for replication the results in the paper is available upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 22, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Caveat to Using Wearable Sensor Data for COVID-19 Detection: The Role of Behavioral Change after Receipt of Test Results
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Caveat to Using Wearable Sensor Data for COVID-19 Detection: The Role of Behavioral Change after Receipt of Test Results
Jennifer L. Cleary, Yu Fang, Srijan Sen, Zhenke Wu
medRxiv 2021.04.17.21255513; doi: https://doi.org/10.1101/2021.04.17.21255513
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A Caveat to Using Wearable Sensor Data for COVID-19 Detection: The Role of Behavioral Change after Receipt of Test Results
Jennifer L. Cleary, Yu Fang, Srijan Sen, Zhenke Wu
medRxiv 2021.04.17.21255513; doi: https://doi.org/10.1101/2021.04.17.21255513

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)